Graham A Mock

Title: Graham A Mock: Innovator in Nucleic Acid Detection

Introduction

Graham A Mock is a notable inventor based in Thame, GB. He has made significant contributions to the field of molecular biology, particularly in the development of innovative methods for nucleic acid detection. With a total of 2 patents to his name, Mock continues to push the boundaries of scientific research.

Latest Patents

One of Graham A Mock's latest patents is focused on modified nucleic acid probes and their use. This patent discloses a method for detecting a nucleic acid sequence of interest in a sample. The method involves using first and second probes, where each probe has complementary and non-complementary portions. The first probe hybridizes to the sequence of interest, while the second probe complements the non-complementary portion of the first probe. This innovative approach allows for the detection of the sequence of interest through the extension of the first probe with a nucleic acid polymerase, using the second probe as a template. The inclusion of a destabilizing moiety in the probes prevents hybridization in the absence of the target sequence, enhancing the specificity of the detection method.

Career Highlights

Graham A Mock has established himself as a key figure in the biotechnology sector. He is currently associated with Cytocell Limited, where he applies his expertise in nucleic acid technologies. His work has contributed to advancements in diagnostic methods and has implications for various applications in research and clinical settings.

Collaborations

Throughout his career, Graham has collaborated with several talented individuals, including Anthony Lee Weston and Rene Assenberg. These collaborations have fostered innovation and have led to the development of cutting-edge technologies in the field.

Conclusion

Graham A Mock is a distinguished inventor whose work in nucleic acid detection has made a significant impact on the scientific community. His innovative patents and collaborations continue to advance the field of molecular biology.